Mucus glycoprotein network (MUC)

The mucus glycoprotein network is a complex, viscoelastic gel that coats mucosal surfaces, providing a critical physical and chemical barrier against pathogens, toxins, and dehydration (Thornton et al., 2008). It is primarily composed of high-molecular-weight, heavily O-glycosylated proteins called mucins, which cross-link via disulfide bonds to form a mesh-like structure (Fahy & Dickey, 2010). These networks are essential for the lubrication and protection of the respiratory, gastrointestinal, and urogenital tracts. In diseases like cystic fibrosis, COPD, and asthma, the network becomes pathologically thickened or hyper-concentrated, leading to airway obstruction and chronic infection (PubMed, 2021). Conversely, in the gastrointestinal tract, degradation of this network can lead to ulcers or inflammatory bowel disease (NIH, 2022). Therapeutic strategies involve mucolytic agents that break disulfide bridges, hydration therapies to reduce viscosity, or inhibitors of mucin secretion to restore normal clearance (StatPearls, 2023). Additionally, the network can be targeted by enzymes that degrade non-mucin components like extracellular DNA, which often accumulates in inflammatory mucus. Understanding the rheological properties of this network is crucial for developing effective treatments for obstructive lung diseases. The network also plays a role in cancer, where overproduction of mucins can facilitate tumor evasion and metastasis. Overall, the mucus glycoprotein network represents a dynamic and multi-component target for maintaining mucosal health and treating chronic inflammatory conditions.

Other names

Mucin networkMucus barrierMucus gelExtracellular mucin matrixMucus blanket

Reduction of disulfide bonds between mucin monomers, enzymatic degradation of extracellular DNA/actin within the network, and enhancement of hydration to decrease viscoelasticity (StatPearls, 2023; PubMed, 2021).